Japanese startup to use RNA technology to develop anti-COVID-19 drug

A biotechnology startup in Japan's Fukuoka Prefecture is partnering with local authorities in an effort to develop a drug to treat COVID-19 using its RNA technology.Bonac Corp., based in Kurume in the southwestern prefecture, says only two other companies in the world are similarly trying to develop a nucleic acid medicine to treat the respiratory disease caused by the novel coronavirus.Under an agreement struck between the company and the Fukuoka prefectural government earlier this week, they will aim at developing an inhaled drug that can directly work on the patient's lungs, thus having …READ FULL ARTICLE